Table 2 Highest 15 statistically significant genes via ANOVA analysis, their fold change and p-values.
From: Gene expression profiling of epithelial ovarian tumours correlated with malignant potential
Affy ID | Gene Name | Gene Symbol | FC a:b | FC a:c | FC c:b | ANOVA p-value |
|---|---|---|---|---|---|---|
1651_at | ubiquitin-conjugating enzyme E2C | UBE2C | 1.16(b) | 4.35(c) | 3.75(c) | 1.2E-07 |
41583_at | flap structure-specific endonuclease 1 | FEN1 | 1.27(b) | 3.86(c) | 3.04(c) | 1.9E-07 |
31888_s_at | tumour suppressing subtransferable candidate 3 | TSSC3 | 3.46(b) | 8.15(c) | 2.36(c) | 2.7E-07 |
34715_at | forkhead box M1 | FOXM1 | 1.06(b) | 2.66(c) | 2.5(c) | 7.5E-07 |
39109_at | chromosome 20 open reading frame 1 | C20orf1 | 1.29(b) | 4.91(c) | 3.80(c) | 2.9E-06 |
37985_at | lamin B1 | LMNB1 | 1.19(b) | 3.19(c) | 2.69(c) | 2.9E-06 |
41451_s_at | SAR1 protein | SAR1 | 1.07(b) | 2.27(c) | 2.13(c) | 3.2E-06 |
37015_at | aldehyde dehydrogenase 1 family, member A1 | ALDH1A1 | 1.86(a) | 10.76(a) | 5.79(b) | 3.3E-06 |
527_at | centromere protein A, 17kDa | CENPA | 1.08(b) | 3.47(c) | 3.2(c) | 3.9E-06 |
40619_at | ubiquitin carrier protein | E2-EPF | 1.51(b) | 2.74(c) | 1.81(c) | 4.6E-06 |
32332_at | isocitrate dehydrogenase 2 (NADP+), mitochondrial | IDH2 | 1.28(b) | 4.36(c) | 3.40(c) | 5.4E-06 |
1058_at | WAS protein family, member 3 | WASF3 | 2.03(a) | 2.56(a) | 1.27(b) | 5.7E-06 |
1943_at | cyclin A2 | CCNA2 | 1.05(a) | 2.07(c) | 2.17(c) | 6.4E-06 |
2039_s_at | FYN oncogene related to SRC, FGR, YES | FYN | 1.05(b) | 3.11(a) | 2.97(b) | 6.4E-06 |
1868_g_at | CASP8 and FADD-like apoptosis regulator | CFLAR | 0.97(b) | 1.78(c) | 1.83(c) | 7.7E-06 |